# Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age

> **NCT01491854** · NA · TERMINATED · sponsor: **Sandoz** · enrollment: 130 (actual)

## Conditions studied

- Short Children Born Small for Gestational Age (SGA)

## Interventions

- **OTHER:** Bloodsampling

## Key facts

- **NCT ID:** NCT01491854
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07-20
- **Primary completion:** 2018-10-31
- **Final completion:** 2018-10-31
- **Target enrollment:** 130 (ACTUAL)
- **Why stopped:** in accordance with the request to close study EP00-402 "EMEA/H/C/000607/MEA 10.2" submitted and adopted by the EMA
- **Last updated:** 2019-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01491854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01491854, "Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01491854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*